Related Experiment Video
Updated: Jun 17, 2025

In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
Striking the Right Chord: Contextual Complexities in Cardiovascular Clinical Trial Representation
Aishat F Mustapha1, Modele O Ogunniyi1,2, Neal W Dickert1,3
1Division of Cardiology, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
No abstract available in PubMed .
More Related Videos
02:47Author Spotlight: Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System
Published on: May 12, 2023
00:04A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Related Concept Videos
Clinical Trials: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Cardiovascular Drugs: Classification based on Therapeutic Indications
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Factors Affecting Drug Response: Overview